CT
Cantabio Pharmaceuticals, Inc.
CTBO · OTC
$1.01 +0.00% (+$0.00)
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 456.60x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CTBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gergely Tóth
Employees
451
Headquarters
Palo Alto